Literature DB >> 8673125

Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene.

Q Zhao1, R R Behringer, B de Crombrugghe.   

Abstract

The paired-class homeobox-containing gene, Cart1, is expressed in forebrain mesenchyme, branchial arches, limb buds and cartilages during embryogenesis. Here, we show that Cart1-homozygous mutant mice are born alive with acrania and meroanencephaly but die soon after birth-a phenotype that strikingly resembles a corresponding human syndrome caused by a neural tube closure defect. Developmental studies suggest that Cart1 is required for forebrain mesenchyme survival and that its absence disrupts cranial neural tube morphogenesis by blocking the initiation of closure in the midbrain region that ultimately leads to the generation of lethal craniofacial defects. Prenatal treatment of Cart1 homozygous mutants with folic acid suppresses the development of the acrania/meroanencephaly phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8673125     DOI: 10.1038/ng0796-275

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  58 in total

1.  Disruption of ALX1 causes extreme microphthalmia and severe facial clefting: expanding the spectrum of autosomal-recessive ALX-related frontonasal dysplasia.

Authors:  Elif Uz; Yasemin Alanay; Dilek Aktas; Ibrahim Vargel; Safak Gucer; Gokhan Tuncbilek; Ferdinand von Eggeling; Engin Yilmaz; Ozgur Deren; Nicole Posorski; Hilal Ozdag; Thomas Liehr; Sevim Balci; Mehmet Alikasifoglu; Bernd Wollnik; Nurten A Akarsu
Journal:  Am J Hum Genet       Date:  2010-05-06       Impact factor: 11.025

Review 2.  Gene expression profiling within the developing neural tube.

Authors:  Richard H Finnell; Wade M Junker; Lisa Kvist Wadman; Robert M Cabrera
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Aristaless-Like Homeobox protein 1 (ALX1) variant associated with craniofacial structure and frontonasal dysplasia in Burmese cats.

Authors:  Leslie A Lyons; Carolyn A Erdman; Robert A Grahn; Michael J Hamilton; Michael J Carter; Christopher R Helps; Hasan Alhaddad; Barbara Gandolfi
Journal:  Dev Biol       Date:  2015-12-02       Impact factor: 3.582

4.  Generation and characterization of a novel neural crest marker allele, Inka1-LacZ, reveals a role for Inka1 in mouse neural tube closure.

Authors:  Bethany S Reid; Thomas D Sargent; Trevor Williams
Journal:  Dev Dyn       Date:  2010-04       Impact factor: 3.780

Review 5.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

Review 6.  Modeling anterior development in mice: diet as modulator of risk for neural tube defects.

Authors:  Claudia Kappen
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

7.  A phenotype-based screen for embryonic lethal mutations in the mouse.

Authors:  A Kasarskis; K Manova; K V Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

8.  Adult rat bones maintain distinct regionalized expression of markers associated with their development.

Authors:  Simon C F Rawlinson; Ian J McKay; Mandeep Ghuman; Claudia Wellmann; Paul Ryan; Saengsome Prajaneh; Gul Zaman; Francis J Hughes; Virginia J Kingsmill
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

9.  Expression of folate pathway genes in the cartilage of Hoxd4 and Hoxc8 transgenic mice.

Authors:  Claudia Kruger; Catherine Talmadge; Claudia Kappen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-04

10.  Midline craniofacial malformations with a lipomatous cephalocele are associated with insufficient closure of the neural tube in the tuft mouse.

Authors:  Keith S K Fong; Dana A T Adachi; Shaun B Chang; Scott Lozanoff
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.